Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GN Store Nord ASGGNDF 74 EV-to-EBIT is 36.52 as of Jul. 19, 2026, which is 38% above its 10-year median of 26.47. GuruFocus rates GGNDF with a GF Score™ of 74/100 and a GF Value™ of $15.90 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 465 Medical Devices & Instruments companies, GN Store Nord AS ranks worse than 80% on this metric.
GN Store Nord AS (OTCPK:GGNDF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
GN Store Nord AS's Enterprise Value for the quarter that ended in Mar. 2026 was $3,409 Mil.
GN Store Nord AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GN Store Nord AS EV-to-EBIT Related Terms
GN Store Nord AS EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for GN Store Nord AS's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, GN Store Nord AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GN Store Nord AS EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GN Store Nord AS's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where GN Store Nord AS's EV-to-EBIT falls into.
GN Store Nord AS's current Enterprise Value is $3,400 Mil.
GN Store Nord AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GN Store Nord AS (GGNDF) has a EV-to-EBIT of 36.52 as of Jul. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on GN Store Nord AS and its competitors. This is 38% above median its historical median of 26.47. Over the past decade, GN Store Nord AS's EV-to-EBIT has ranged from 13.49 to 56.87. According to the industry distribution chart, GN Store Nord AS ranks #372 out of 465 companies in the Medical Devices & Instruments industry, placing it in the top 80%.
Is GN Store Nord AS's EV-to-EBIT too high?
GN Store Nord AS's current EV-to-EBIT of 36.52 is 38% above median its 10-year median of 26.47. Over the past 10 years, this metric has ranged from a low of 13.49 to a high of 56.87. The Medical Devices & Instruments industry median EV-to-EBIT is 18.43. GN Store Nord AS's value of 36.52 is 98.2% above this industry median. Based on the distribution chart, GN Store Nord AS ranks #372 out of 465 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, GN Store Nord AS has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GN Store Nord AS's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, GN Store Nord AS ranks #372 out of 465 companies for EV-to-EBIT. This places GN Store Nord AS in the lower half of its industry. The industry median EV-to-EBIT is 18.43. GN Store Nord AS's value of 36.52 is 98.2% above this benchmark. Historically, GN Store Nord AS's own EV-to-EBIT has ranged from 13.49 to 56.87 over the past decade. While the company's 10-year median is 26.47 vs. the industry median of 18.43, GN Store Nord AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.43, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GN Store Nord AS's current EV-to-EBIT of 36.52 is 98.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on GN Store Nord AS and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GN Store Nord AS's current EV-to-EBIT is 36.52, which is 38% above median its own 10-year median of 26.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GN Store Nord AS stock overvalued right now?
Based on GuruFocus' analysis, GN Store Nord AS (GGNDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $15.90, compared to a current price of $13.39 — trading 15.8% below its estimated fair value. The current EV-to-EBIT is 36.52, which is 38% above median its 10-year median of 26.47 and 98.2% above the Medical Devices & Instruments industry median of 18.43. GN Store Nord AS's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For GN Store Nord AS (GGNDF), the current EV-to-EBIT is 36.52 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GN Store Nord AS (GGNDF) Overvalued in 2026?
Based on GuruFocus' analysis, GN Store Nord AS stock appears to be undervalued.
The current stock price of $13.39 is trading 15.8% below its estimated GF Value™ of $15.90.
GuruFocus considers GN Store Nord AS to be Modestly Undervalued.
Key valuation signals for GGNDF:
EV-to-EBIT: 36.52 (38% above median its 10-year median of 26.47)
GF Value™: $15.90 vs. price of $13.39 (15.8% below fair value)
Industry Position: 98.2% above the Medical Devices & Instruments median (#372 of 465)
No single metric tells the full story. See the GGNDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GN Store Nord is a Danish company offering medical and audio solutions. The group comprises three businesses: hearing (about 40% of sales), enterprise (40%), and gaming (20%). GN Hearing offers hearing aids and competes globally with Sonova, Demant, Starkey, and WS Audiology (formerly Sivantos and Widex). GN Enterprise provides headsets and speakerphones to the enterprise market, including contact centers and offices. GN recently acquired SteelSeries, a provider of gaming accessories such as headsets and keyboards, thereby forming the gaming division. The company has positioned itself as a major player in the Unified Communication-enabled headsets market. The firm's premium brands are Resound in hearing, Jabra in headsets, and SteelSeries in gaming.
74GF Score
Get the complete analysis for GGNDF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GGNDF has been successfully added to your 
